Did a Compounding Pharmacy Just Nullify Trump's Drug Rx?

The pressure from the Trump administration's Most Favored Nation push forced major players like Novo Nordisk to consider lower prices. But just as the dust seemed to settle with the release of a new, seemingly compliant product, an unexpected challenge emerged from the compounding sector. See how a seemingly simple policy directive created a tangled mess of market uncertainty for drug manufacturers. A fascinating look at policy meets market maneuver.
#TrumpRx #DrugPricing #Pharmaceuticals #NovoNordisk #HealthcarePolicy #Meds

Видео Did a Compounding Pharmacy Just Nullify Trump's Drug Rx? канала Dan Sfera